MILESTONE SCIENTIFIC INC.
MILESTONE SCIENTIFIC INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Marketable Securities Current | - | - | - | - | - | - | 0 | 0 | 0 | 1 | 3 | 2 | |||||
Cash | 2 | 1 | - | - | - | - | - | - | - | - | - | - | |||||
Cash And Cash Equivalents At Carrying Value | - | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 6 | 4 | 3 | 2 | |||||
Accounts Receivable Net Current | - | - | - | - | - | - | 0 | 1 | 0 | 1 | 0 | 1 | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Inventory Net | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 2 | |||||
Advances On Inventory Purchases | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |||||
Assets Current | 8 | 7 | 7 | 8 | 8 | 9 | 9 | 11 | 11 | 11 | 11 | 10 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Finance Lease Right Of Use Asset | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deferred Finance Costs Net | - | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 8 | 8 | 8 | 8 | 8 | 9 | 10 | 11 | 12 | 11 | 11 | 11 | |||||
Accrued Liabilities Current | - | - | - | - | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Finance Lease Liability Current | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 4 | 5 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | |||||
Finance Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Long Term Notes Payable | - | - | - | - | 1 | - | - | - | - | - | - | - | |||||
Convertible Long Term Notes Payable | 0 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | |||||
Liabilities | 5 | 6 | 5 | 6 | 5 | 5 | 4 | 4 | 4 | 4 | 3 | 4 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 140 | 138 | 137 | 136 | 136 | 135 | 135 | 134 | 133 | 133 | 132 | 129 | |||||
Retained Earnings Accumulated Deficit | -136 | -135 | -134 | -133 | -132 | -130 | -128 | -126 | -125 | -125 | -123 | -121 | |||||
Treasury Stock Value | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |||||
Stockholders Equity | 3 | 2 | 3 | 3 | 3 | 4 | 6 | 7 | 8 | 7 | 8 | 7 | |||||
Liabilities And Stockholders Equity | 8 | 8 | 8 | 8 | 8 | 9 | 10 | 11 | 12 | 11 | 11 | 11 | |||||
Minority Interest | - | - | - | - | - | - | - | - | - | - | 0 | -0 | |||||
Allowance For Doubtful Accounts Receivable | - | 0 | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | - | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 125 | 125 | 125 | 100 | 100 | 100 | 125 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 89 | 80 | 80 | 79 | 79 | 78 | 78 | 78 | 77 | 77 | 76 | 71 | |||||
Shares Outstanding | 89 | 80 | 80 | 79 | 79 | 78 | 78 | 78 | 77 | 77 | 76 | 71 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 20.00% | -2.86% | 11.43% | - | - | - | - | - | - | - | - | - |
| 2025 | -2.15% | -27.96% | -53.76% | 6.90% | -24.14% | -27.59% | -7.89% | -23.68% | -26.32% | 10.34% | 31.03% | 27.59% |
| 2024 | 5.80% | -4.35% | 36.23% | 1.98% | -12.87% | -19.80% | 30.88% | 39.71% | 85.29% | -1.04% | -5.21% | -30.21% |
| 2023 | - | - | - | -27.48% | -29.77% | -35.11% | -14.46% | -24.10% | -27.71% | - | - | - |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.85 | 1.51 | 1.81 | 1.61 | 2.03 | 1.94 | 2.48 | 2.85 | 3.00 | 2.97 | 3.51 | 3.04 | |||||
| Quick Ratio | 1.00 | 0.66 | 0.78 | 0.69 | 0.82 | 0.84 | 1.34 | 1.69 | 1.93 | 1.95 | 2.48 | 2.11 | |||||
| Working Capital | 3.72M | 2.50M | 3.35M | 3.08M | 3.86M | 4.18M | 5.54M | 6.94M | 7.67M | 7.18M | 7.72M | 6.69M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 1.41 | 2.48 | 1.78 | 2.33 | 1.41 | 1.04 | 0.68 | 0.55 | 0.51 | 0.52 | 0.42 | 0.50 | |||||
| Interest Coverage TTM | -92.45 | -103.64 | -161.95 | -87.01 | -107.51 | -86.27 | -63.88 | -87.65 | -68.02 | -57.05 | -56.61 | -54.74 | |||||
| Debt Ratio | 0.58 | 0.71 | 0.64 | 0.70 | 0.59 | 0.51 | 0.40 | 0.35 | 0.34 | 0.34 | 0.30 | 0.32 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.15 | 1.04 | 1.02 | 0.91 | 0.91 | 0.84 | 0.82 | 0.79 | 0.72 | 0.80 | 0.78 | 0.74 | |||||
| Days Sales Outstanding TTM | - | - | - | - | - | - | 16.66 | 23.48 | 25.49 | 30.31 | 18.69 | 31.31 | |||||
| Receivables Turnover TTM | - | - | - | - | - | - | 21.90 | 15.55 | 14.32 | 12.04 | 19.53 | 11.66 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.04 | -0.05 | -0.07 | -0.08 | -0.09 | -0.06 | -0.06 | -0.06 | -0.06 | - | - | - | |||||
| Free Cash Flow Per Share TTM | -0.01 | -0.02 | -0.04 | -0.05 | -0.06 | -0.03 | -0.04 | -0.03 | -0.03 | -0.06 | -0.07 | -0.07 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 70.23% | 71.03% | 71.40% | 71.86% | 72.80% | 74.37% | 74.56% | 72.47% | 72.43% | 69.41% | 69.12% | 64.93% | |||||
| Operating Profit Margin TTM | -43.56% | -50.84% | -63.48% | -74.58% | -77.00% | -84.63% | -78.30% | -75.41% | -79.93% | -76.26% | -72.31% | -72.82% | |||||
| Net Profit Margin TTM | -43.98% | -51.30% | -63.76% | -74.66% | -76.78% | -61.16% | -54.62% | -51.77% | -54.74% | -74.38% | -70.51% | -71.50% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 3.72% | 3.37% | 3.99% | 0.59% | 7.84% | -9.13% | -12.19% | -9.49% | -15.47% | 8.92% | 11.60% | 4.22% | |||||
| Net Income Growth (1Y) | -40.59% | -13.29% | 21.40% | 45.08% | 51.28% | -25.28% | -31.97% | -34.47% | -38.59% | -13.74% | -21.02% | -10.89% | |||||
| EPS Growth (1Y) | -47.65% | -16.54% | 18.04% | 40.93% | 47.44% | -27.22% | -37.95% | -39.58% | -44.46% | -22.00% | -23.37% | -14.22% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -7.19 | -5.40 | -3.87 | -5.56 | -7.53 | -14.45 | -16.25 | -15.84 | -11.79 | -7.01 | -7.25 | -9.67 | |||||
| P/B TTM | 8.59 | 10.79 | 7.88 | 14.53 | 15.72 | 17.06 | 13.13 | 10.08 | 6.84 | 6.63 | 6.27 | 9.36 | |||||
| P/S TTM | 3.16 | 2.77 | 2.47 | 4.15 | 5.78 | 8.84 | 8.88 | 8.20 | 6.46 | 5.22 | 5.11 | 6.92 | |||||
| Market Cap | 29.80M | 24.66M | 22.16M | 37.05M | 52.51M | 76.12M | 76.60M | 72.77M | 54.38M | 49.44M | 50.22M | 67.83M | |||||
| Enterprise Value | 28.20M | 24.31M | 21.90M | 36.56M | 52.10M | 73.94M | 73.41M | 68.00M | 48.63M | 45.44M | 47.25M | 65.67M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -657.76K | -1.84M | -2.93M | -4.22M | -5.27M | -2.72M | -2.93M | -2.66M | -2.73M | -4.54M | -5.33M | -5.18M | |||||
| Net Debt | -1.60M | -348.75K | -257.96K | -487.21K | -412.81K | -2.18M | -3.19M | -4.77M | -5.75M | -4.00M | -2.97M | -2.16M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
MILESTONE SCIENTIFIC INC. (MLSS) — SEC Financial Statements & Analysis
MILESTONE SCIENTIFIC INC. (MLSS) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. MILESTONE SCIENTIFIC INC. trades on NYSE as: MLSS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MILESTONE SCIENTIFIC INC. reported a 3.72% year-over-year revenue growth, a Gross Profit Margin of 70.23% (TTM), a Debt-to-Equity ratio of 1.41x, a Price-to-Sales (P/S) ratio of 3.16x (TTM), a Price-to-Book (P/B) ratio of 8.59x (TTM), at a market cap of $29.80M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 3.72%
- Gross Profit Margin TTM
- 70.23%
- Debt To Equity
- 1.41x
- P/S TTM
- 3.16x
- P/B TTM
- 8.59x
- Market Cap
- $29.80M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MILESTONE SCIENTIFIC INC. in?
MILESTONE SCIENTIFIC INC. (MLSS) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
What is MLSS's market cap?
MILESTONE SCIENTIFIC INC. (MLSS) has a market capitalization of $29.80M as of 2026-06-30.
What exchange does MLSS trade on?
MILESTONE SCIENTIFIC INC. (MLSS) trades on the NYSE.
Where is MILESTONE SCIENTIFIC INC. incorporated?
MILESTONE SCIENTIFIC INC. is incorporated in DE.